Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Over 20 industry experts on Inhalaltion Drug Delivery to gather in Berlin on 11 - 12 September 2013

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
CPhI Conferences introduces its inaugural conference on Inhalation Drug Delivery, to cover topics from particle engineering to device manufacture.

The potential of a pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving an undeniable attention with the recent advances of the inhalation drug delivery showing significant promise.  The crucial formulation considerations for orally inhaled products together with those of a delivery device play a major role in the efficiency of pulmonary delivery, and great strides have been made in the development of new formulation techniques and devices in recent years.

With this in mind, CPhI Conferences, is proud to present its inaugural conference on Inhalation Drug Delivery which has been designed to examine all the important aspects of pulmonary drug delivery, from particle engineering to device manufacturing.

Over the course of two intensive days there will be practical and informative sessions examining technical, physiological, and efficacy aspects of the novel pulmonary route of drug targeting. It will share important insights into the mechanisms of pulmonary drug administration along with compatibility of the excipients employed, devices used, and techniques of particulate dosage production.

This is an essential opportunity to understand the challenges facing the development of pulmonary drug delivery system and discover the opportunities for the pharmaceutical scientists to minimize the clinical and technical gaps.

In addition to the main conference, CPhI is also running a Pre-Conference Workshop on Nasal Drug Delivery providing hands-on, practical guidance on how to capitalise on the full potential of delivering drugs via the nasal route.

The conference will include industry professionals from a range of organisations including MHRA, Catalent, Glenmark, Hovione, Medicon Valley Inhalation Consortium, KAER Biotherapeutics, Nonomol Technologies and many more. With expert speakers from the world of pulmonary drug delivery across Europe and globally, this conference offers the opportunity to network and debate with leaders in this field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Smart Patch Releases Blood Thinners When Needed
Researchers have developed a smart patch that activelly monitors a patient's blood and releases blood thinning drugs when necessary.
First-Ever Capsule to Treat Hemophilia
In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
New Compound to Reduce Tumor Growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Long-Lasting Pill to Fight Malaria
An ultra-long acting pill has been developed to offer a new hope in eliminating malaria.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Synthetic Protein Captures DNA Events Leading to Cancer
A team of scientists have developed new technology allowing them to identify molecular intermediates that can drive genetic change.
Precision Medicine for Rheumatoid Arthritis
Researchers identify gene mechanism that increases rheumatoid arthritis risk in susceptable individuals.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!